MedTrace Logo

Perineural Dexmedetomidine in Adductor Canal Block

NCT03030950 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-01-15

No results posted yet for this study

Summary

This study is designed to explore the effects of peri-neural dexmedetomidine on the duration and motor sparing potentials of adductor canal block in adult patients undergoing arthroscopic medical meniscectomy in the setting of multimodal analgesia. The investigators ultimate goal is to increase the postoperative analgesic time and to preserve quadriceps muscle strength to promote safe and early ambulation.

Conditions

  • Arthroscopic Medial Meniscectomy

Interventions

DRUG

Dexmedetomidine

to investigate the effect of dexmedetomidine on motor and sensory properties of adductor canal block

DRUG

Normal saline

to give normal saline to the other group as a placebo

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed Abdulatif, Professor · Professor and member of research committee of anesthesia department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-25
Primary Completion
2018-12-01
Completion
2018-12-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03030950 on ClinicalTrials.gov